05 · Events & Convenings
Where we listen,
and where we learn.
Long-horizon capital is built on conviction, and conviction is built in rooms — at the scientific summits, policy forums and industry convenings that quietly redraw the map of what is possible.
Biotechnology · Featured
Second International Summit on Human Genome Editing
Convened by the Academy of Sciences of Hong Kong, the Royal Society, the U.S. National Academy of Sciences and the U.S. National Academy of Medicine, the summit brought together the world's leading geneticists, ethicists and capital allocators to confront the new realities of CRISPR-based human genome editing.
FMK Holding AG attended as a long-horizon allocator into biotechnology — to listen, to challenge our assumptions, and to refine the ethical and scientific frameworks that today guide how we deploy capital into life sciences.
- Location
- Hong Kong SAR
- Dates
- 27 – 29 Nov 2018
- Theme
- Human Genome Editing
- Attendance
- Observer · Limited delegation
“The room where the rules of biotechnology are being rewritten is not always the room where the cheques are being written. We try to be in both.”
FMK Holding AG — Internal note, December 2018